the rise in blood glucose levels in many patients, the continuous use of these drugs is often associated with undesirable side effects, such as liver toxicity and adverse gastrointestinal symptoms 4, 5 . To this end, there is a need for natural α-amylase and α-glucosidase inhibitors which have low or unwanted secondary effects. Olea europea L. leaves are known to contain various bioactive substances with diverse health benefits. Oleuropein appears to be the principal phenolic compound. Its concentration varies with cultivar and climate 6 . Following hydrolysis, oleuropein can produce other bioactive substances, especially hydroxytyrosol. Several in vitro and in vivo studies have shown that oleuropein and its derivate hydroxytyrosol possess a wide range of biochemical and pharmacological properties 7 . It was also reported that ble state in diabetes 9 . In fact, the inhibitory activity of oleuropein s aglycon and luteolin glucosides luteolin-7-O-β-glucoside and luteolin-4 -O-β-glucoside against pancreatic amylase were determined 8 . However, the antidiabetic effects of hydroxytyrosol component have not yet been investigated against α-glucosidase and α-amylase. Therefore, the aim of this study is to evaluate the inhibitory effect of hydroxytyrosol against α-glucosidase and pancreatic α-amylase and to compare those observed effects to oleuropein. Enzyme kinetic studies using MichaelisMenten and the derived Lineweaver-Burk LB plots were performed to understand the possible mode of inhibition of these phenolic compounds.
EXPERIMENTAL

Chemicals
Saccharomyces cerevisiae α-glucosidase ≥ 10 U/mg , pancreatic α-amylase ≥ 250 U/mg , and acarbose BJ05882 were purchased from Sigma-Aldrich St. Louis, MO, USA . All other chemicals used for the analyses were obtained from sigma-Aldrich.
Olive leaves extract preparation
Olive leaves 200 g were dried in a microwave oven three times for 2 min at maximum power 1250 W . Dried leaves were powdered and stored under dryness in the dark until extraction.
Olive leaves powder 60 g was extracted with a mixture of methanol and water 300 ml, 4:1 vol/vol overnight under agitation in the dark. Then, the solution was filtered using GF/F filter paper. The filtrate was hydrolyzed at 100 for 1 h using a 2 M HCl solution 4:1 vol/vol . The sample was then cooled and monomeric phenolics were extracted by a separatory funnel three times with ethyl acetate which was subsequently removed by evaporation and the residue was stored for further analyses.
HPLC analysis
Chromatographic analyses were achieved on an Agilent series 1260 HPLC-DAD instrument Agilent, Waldbronn. Germany . The instrument includes a quaternary pump, an online degasser, an auto sampler and a thermostatically controlled column compartment. Chromatographic separation was carried out on a ZORBAX Eclispe XDB-C18 column serial number USNH027266 4.6 mm I.D. 250 mm 3.5 mm particle size . The mobile phase was made of solvent A 0.1 acetic acid and solvent B Acetonitrile .
The running gradient was as follows: 0-22 min, 10 -50 B, 22-32 min, 50 -100 B; 32-40 min, 40-44 min, 100-10 B. Re-equilibration duration lasted 6 min. The flow rate was adjusted at 0.5 mL/min, the injection volume of 10 mL and operating temperature was set at 40 . The DAD detector scanned from 190 to 400 nm and the samples were detected at 254, 280 and 330 nm.
2.4 Purification of hydroxytyrosol using semipreparative HPLC The hydroxytyrosol was purified using semipreparative HPLC Knauer, Germany . The experiment was conducted on a model liquid chromatograph fitted with a eurospher C18 column Knauer, Germany with dimensions of 250 mm 9.4 mm I.D. Here, 0.1 phosphoric acid aqueous solution A and 100 acetonitrile B were used as the mobile phases at a flow rate of 2 mL/min. The gradient started at 10 B and was kept for 8 min, then increased to 100 B for 32 min. The isocratic gradient was kept for 8 min, and finally acetonitrile was decreased to 10 B at 56 min. An eluted peak of hydroxytyrosol was collected using a model sampler. The collected hydroxytyrosol solution was pooled, concentrated using a rotary evaporator and further. The purity level of oleuropein was determined using LC-MS/MS Agilent 1100 LC, Germany equipment.
Maintenance of cell line
Human colonic carcinoma Caco-2 cells were maintained in Dulbecco s Modified Eagle s Medium DMEM supplemented with 10 v/v heat-inactivated fetal bovine serum FBS , 2 mM L-glutamine and 1 non-essential amino acids. The cells were grown at 37 at 5 CO 2 in a humidified incubator. Exponentially growing cells were used throughout.
Assessment of cell viability
Cytotoxicity of the pure compounds was measured using the MTT 3-4,5-Dimethylthiazol-2-yl -2, 5-diphenyltetrazolium bromide assay. This assay requires cells that are metabolically active and able to reduce MTT to an insoluble formazan and which later dissolved in 10 sodium dodecyl sulfate SDS and detected at 570 nm. Briefly, cells were treated with oleuropein or hydroxytyrosol 100-600 mM in a 96-well plate for 24 h and 48 h. Cell viability was reported as a percentage of viable cells compared to control cells cells treated with medium only .
α-Amylase assay
Appropriate compounds at different concentrations 100 mM -600 mM and 500 ml of 0.02 M sodium phosphate buffer pH 6.9 with 0.006 M NaCl containing porcine pancreatic α-amylase EC 3.2.1.1 0.5 mg/ml were incubated at 25 for 10 min. Then, 500 ml of 1 starch solution in 0.02 M sodium phosphate buffer pH 6.9 with 0.006 M NaCl was added to each tube. The reaction mixture was further incubated at 25 for 10 min and stopped with 5.0 ml of 3,5-dinitrosalicylic acid color reagent and the mixture was incubated in a boiling water for 10 min at 100 . The reaction mixture was then diluted by adding 10 ml of distilled water, and the absorbance was measured at 540 nm. The α-amylase inhibitory activity was expressed as percentage inhibition 10 .
α-Glucosidase inhibition assay
The α-glucosidase assay was performed, using the method of Liu et al. on 96-well plates with some modifications 11 . 50 ml of appropriate dilution of extracts and 100 ml of α-glucosidase solution 1.0 U/ml in 0.1 M phosphate buffer pH 6.9 was incubated at 25 for 10 min. Then, 50 ml of 5 mM p-nitrophenyl-α-D-glucopyranoside pNPG solution in 0.1 M phosphate was added. The mixtures were further incubated at 25 for 5 min, before reading the absorbance at 405 nm in the spectrophotometer. The α-glucosidase inhibitory activity was expressed as percentage inhibition 12 .
IC 50 determination
Active compounds were assessed for their potency through the determination of their IC 50 values. This is defined as the concentration of an inhibitor required for reducing 50 of the enzyme activity obtained from an activity versus concentration plot. The data points were fitted into a nonlinear sigmoid plot to take into account non-linear concentration dependent of enzyme -inhibitor interaction at low and high concentrations 13 .
Determination of the inhibitory mode of action
The kinetic mode of inhibition of the active compounds against α-glucosidase was determined by preparing a series of sample solutions in which the concentration of the substrate was varied 1 -5 mM in the absence or presence of different concentrations of the inhibitor. The inhibition mode of the test compounds was evaluated on the basis of the inhibitory effects on K m dissociation constant and V max maximum reaction velocity of the enzyme 13 . This can be determined using the Lineweaver-Burk plot, which is the double reciprocal plot of enzyme reaction velocity V versus substrate pNPG concentration 1/V versus 1/ pNPG .
Statistics analysis
The results of four experiments were pooled and expressed as mean standard deviation SD . Data were subjected to a one-way analysis of variance ANOVA using SPSS 19 statistical package SPSS Ltd., Woking, UK followed by Tukey post hoc tests. Differences were considered significant when p 0.05.
RESULTS
Preparation of olive phenolic compounds
HPLC chromatograms of the olive leaves extract and purified hydroxytyrosol are depicted in Fig. 1 A and B , respectively. The acid hydrolysis of the methanolic extract of olive leaves resulted in the cleavage of oleuropein, the principle polyphenolic compound of olive leaves, into the ortho-diphenolic compound hydroxytyrosol Hyd . The UV-HPLC spectra of the olive leaves extract before and after purification have shown respective pics of oleuropein OLE and hydroxytyrosol. The extraction yield of oleuropein was 8 of the dry leaves weight and purified hydroxytyrosol was 10 molar yield of extracted oleuropein.
The chromatogram of Fig. 1B depicts a sharp monomodal peak of hydroxytyrosol at a retention time of 10 min. The hydroxytyrosol purity, determined by LC-MS-MS was higher than 99 .
Inhibitory effect of active compounds on yeast
α-glucosidase The α-glucosidase inhibitory activity was measured in the concentration range of 100 -600 mM , for both oleuropein and hydroxytyrosol. Results are illustrated in Fig. 2 . α-Glucosidase inhibitory activity was increased significantly p 0.05 in a dose dependent manner relatively to the concentration of active compounds. The hydroxytyrosol reached the highest α-glucosidase inhibitory 75 activity at 600 mM and at this concentration, the inhibitory activity of hydroxytyrosol, acarbose and oleuropein were about 75, 65 and 55 , respectively. Based on IC 50 values, it can be seen that the hydroxytyrosol was the potent inhibitor of the α-glucosidase, with an IC 50 of 150 mM which was higher than of acarbose IC 50 200 mM and much higher than that of oleuropein 400 mM .
Inhibitory effects on pancreatic α-amylase
The inhibitory activities of olive compounds against pancreatic amylase were also studied. At the highest concentration, the hydroxytyrosol and the oleuropein were not effective as less than 25 and 10 , activity inhibition were observed, respectively data not shown .
Mode of inhibition
In the present study, the initial velocity v of the hydrolysis reactions catalyzed by α-glucosidase was measured at various substrate concentrations S in the presence or absence of test compounds I , as illustrated in Fig. 3 . The slope s and vertical axis intercept i increase with increasing hydroxytyrosol concentration. This result indicates that hydroxytyrosol affected the velocity of the reaction catalyzed by α-glucosidase, without affecting the Michaelis constant K m . Therefore, we conclude that a noncompetitive inhibition occurs in the presence of hydroxytyrosol. Kinetic constants for the inhibition of α-glucosidase are shown in determined mM of hydroxytyrosol were found to be 71.10 and 50.5 mmoles min 1 , respectively. The inhibition constants for inhibitor binding with the free enzyme to form EI or with the enzyme-substrate complex to form ESI were determined using the secondary plot Fig. 3B and the secondary replot Fig. 3C , respectively. Using the secondary plot representing slopes K m /V max of the double reciprocal plots against the inhibitor concentration an EI dissociation constant K i of 104.1 mM was determined, whereas using the secondary replot representing intercept of the double reciprocal relation against the inhibitor concentration an ESI dissociation constant K is of 150.1 mM was obtained.
In contrast, the presence of oleuropein in the reaction mixture resulted in no intersection of the straight lines lines are parallel in the LB plot Fig. 4 . In this case, we conclude that an uncompetitive took place, where the inhibitor only binds to the enzyme substrate complex resulting in a change of both K m and V max . The uncompetitive inhibition exerted, indicated that binding of starch at the
Fig. 1 HPLC chromatograms at 280 nm of olive leaves extract (A), and highly purified hydroxytyrosol (B).
catalytic site may have modified the confirmation of α-glucosidase, making the putative inhibitor binding site available.
Cell viability
While the antidiabetic effects of oleuropein and hydroxytyrosol have been established, this study also aims to validate the efficacy of the extracts as prospective functional food ingredients. The determination of the toxicological potential is important to predict the consequences of exposure at different dose levels 14 . Following 24 h exposure and 48 h exposure to both compounds, no cytotoxic effects were observed at least for IC 50 values being 150 and 400 mM, previously determined for hydroxytyrosol and oleuropein, respectively p 0.05 . Whereas, at the highest concentration 600 mM , the hydroxytyrosol significantly decreased viability of the Caco-2 cells p 0.05 Fig. 5A and B . Also, it is worth noting that after 48 h exposure, the hydroxytyrosol had a substantial inhibitory effect on Caco-2 viability 40 , however, in the case of the oleuropein, there s an increase in cell number compared to control p 0.05 .
DISCUSSION
The control of postprandial hyperglycemia is critical in the early intervention and prevention of diabetic complications for type 2 diabetes management 15 . α-Glucosidase and α-amylase are two key enzymes related to carbohydrate digestion and elevation of blood glucose levels within fasting subjects. It is now believed that the inhibition of these enzymes might be recognized as a therapeutic strategy for reducing hyperglycemia 16 . Plant phenolic compounds, as potential inhibitors have been shown to inhibit these digestive enzymes. In fact, α-glucosidase and pancreatic amylase activities were effectively reduced by naringenin, kaempferol, luteolin, apigenin, -catechin/ -epicatechin, diadzein and epigallocatechin gallate 17 .
In this present study, we investigate for the first time the effect of hydroxytyrosol and oleuropein on digestive enzymes. Our results revealed that hydroxytyrosol exert a higher inhibition against α-glucosidase compared to the oleuropein. Indeed, the inhibition rate for α-glucosidase was close to that of acarbose, and the inhibition rate for α-amylase was obviously lower than that of acarbose. This indicated that hydroxytyrosol was a strong inhibitor for α-glucosidase with a mild inhibition against α-amylase. This findings support earlier reports by Loizzo et al. who showed that olive oil extracts were weaker inhibitors of α-amylase compared to α-glucosidase 18 . Pharmaceutically, strong inhibitors of α-glucosidase with mild inhibitory activity against α-amylase have been sought due to their great importance in order to prevent the abnormal bacterial fermentation of undigested carbohydrates in the colon, which results in flatulence and diarrhea 4 . Given that oleuropein and hydroxytyrosol have a lower inhibitory effect against α-amylase and stronger inhibitory activity against α-glucosidase they may form the basis of a particularly effective therapy for postprandial hyperglycemia with minimal side effects. Several reports have investigated the inhibitory effect of luteolin and luteolin-7-O-glucoside against α-glucosidase and α-amylase. In fact, luteolin inhibited α-glucosidase by 36 and was stronger than acarbose, whereas its inhibitory effect against α-amylase was less potent than acarbose 19 . On the other hand, gallic acid, vanillic acid, quercetin and p-coumaric acid isolated from finger millet were shown to be potent inhibitors against α-amylase with respective inhibition of 67.7 , 71.9 , 73.5 and 62.5 and showed uncompetitive inhibition 20 .
In order to determine the inhibition constant and the enzymatic model of the inhibition, competitive, noncompetitive or uncompetitive type and whether it occurs in the steady state, we have outlined the Lineweaver-Burk representation. Experimental data showed that hydroxytyrosol has the capacity to inhibit the activity of the α-glucosidase with K i value of 104.1 mM. In addition, hydroxytyrosol was revealed to exert a noncompetitive inhibition whereas oleuropein exhibited an uncompetitive inhibition. The difference in the inhibitory potencies of hydroxytyrosol and oleuropein can be associated with variation in the molecular structures. In fact, hydroxytyrosol had a polar structure giving it a high capability to interact directly with the enzymes α-glucosidase which the enzyme and phenolic glycosidic conjugates is expected to be higher than the non-glycosidic-molecules.
The effect of hydroxytyrosol and oleuropein on Caco-2 was established and these findings demonstrate that the IC 50 of hydroxytyrosol and oleuropein for α-glucosidase inhibition were greatly below cytotoxic levels. These results are somewhat in contrast with those reported by Mateos et al. who showed that the hydroxytyrosol affect the viability of the Caco-2 from 100 mM. However, the authors only document the cytotoxic effects at 24 h 22 .
On the other hand, the inhibition of Caco-2 cells proliferation by olive compounds has been found to be related to the antioxidant properties of such compounds 23 . Therefore, antioxidants may prevent the progressive impairment of pancreatic beta-cell function and thus reduce the occurrence of type 2 diabetes 24 . Researchers pay much more attention to antioxidant activities when antidiabetic activities of phytochemicals, especially phenolics, were evaluated, and it was reported that several phenolic compounds with inhibitory activities against α-glucosidase and α-amylase had moderate antioxidant activity 25 27 .
Although this study focuses on the antidiabetic potential of olive leaves compounds hydroxytyrosol and oleuropein , and the Caco-2 cell line which was used as a model for cultured colonocytes, the observed findings could also be looked at from a chemotherapeutic perspective. Owing to their cytotoxic effects, 400 mM of the hydroxytyrosol could potentially be employed in the inhibition of cancer development.
CONCLUSION
With the increasing prevalence of type II diabetes, efforts are being made to identify natural therapies that can control hyperglycaemia. In the present study, we demonstrate the efficacy of hydroxytyrosol to inhibit enzymes involved in intestinal carbohydrate digestion and assimilation, namely α-glucosidase. Due to it availability and strong inhibitory properties, hydroxytyrosol has potential for use in functional food applications. Additionally, the strong α-glucosidase inhibition at non-cytotoxic levels and mild inhibition of α-amylase makes the extracts a good source for the management of type-2 diabetes with minimum side effects currently observed with some of the drugs being used for the management of non-insulin dependent diabetes mellitus.
